Trusting Her Gut Emergency room case manager and nurse Marla Celeri had been struggling with a runny nose, persistent cough, rapid breathing and a hoarse voice for six months. Unable to speak above a whisper, Marla checked in to
...
from CBS News: Lung cancer rates have been historically higher among men than women, but new research reveals that trend has flipped in younger Americans. Over the past two decades, while lung cancer rates have generally gone down, women…
Vanderbilt University Christine Lovly, MD, PhD, assistant professor of Medicine, has received a $200,000 grant to support promising new research on lung cancer. The Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung…
Like people, no two lung cancer tumors are the same. Personalized medicine (also known as precision medicine) is the idea of tailoring treatment to each patient. This takes into account both patient and specific tumor characteristics. Instead of using more
...
Within 2016, the FDA approved two immunotherapies – also called checkpoint inhibitors – for people with some forms of lung cancer whose cancer starts growing again after other treatment. In October, 2016, the FDA approved Tencentriq (atezolizumab) for second line
...